There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
A post-marketing surveillance study evaluating the sensitivity of the Individual Symptom
Score (IndiSS) in assessing the treatment benefits of donepezil in patients with Alzheimer's
disease (AD) under everyday conditions.
[1
]
Department of Psychiatry, Mental Health and Old Age Psychiatry, Charité Universitätsmedizin,
Berlin, Germany. matthias.riepe@charite.de <riepe@charite.de>